Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-7-23
pubmed:abstractText
Growth arrest-specific protein 6 (Gas 6) is involved in inflammatory kidney diseases, vascular remodeling, cell adhesion, and thrombus formation. We explored a role for Gas 6 in aldosterone-induced target organ damage. We observed that Gas 6 was upregulated in rats with high aldosterone levels. Mineralocorticoid receptor blockade prevented target organ damage and decreased the elevated Gas 6 expression. Vascular smooth muscle cells given aldosterone increased their Gas 6 expression in vitro. To test the pathophysiological relevance, we investigated the effects of deoxycorticosterone acetate (DOCA) on Gas 6 gene-deleted ((-/-)) mice. After 6 weeks DOCA, Gas 6(-/-) mice developed similar telemetric blood pressure elevations compared to wild-type mice but were protected from cardiac hypertrophy. Cardiac expression of interleukin 6 and collagen IV was blunted in Gas 6(-/-) mice, indicating reduced inflammation and fibrosis. Gas 6(-/-) mice also had an improved renal function with reduced albuminuria, compared to wild-type mice. Renal fibrosis and fibronectin deposition in the kidney were also reduced. Gas 6 deficiency reduces the detrimental effects of aldosterone on cardiac and renal remodeling independent of blood pressure reduction. Gas 6 appears to play a role in mineralocorticoid receptor-mediated target organ damage. Furthermore, because warfarin interferes with Gas 6 protein expression, the findings could be of clinical relevance for anticoagulant choices.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1524-4563
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
359-64
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19564549-Acute Kidney Injury, pubmed-meshheading:19564549-Albuminuria, pubmed-meshheading:19564549-Aldosterone, pubmed-meshheading:19564549-Analysis of Variance, pubmed-meshheading:19564549-Animals, pubmed-meshheading:19564549-Blood Pressure, pubmed-meshheading:19564549-Cardiomegaly, pubmed-meshheading:19564549-Cells, Cultured, pubmed-meshheading:19564549-Desoxycorticosterone, pubmed-meshheading:19564549-Disease Models, Animal, pubmed-meshheading:19564549-Gene Expression Regulation, pubmed-meshheading:19564549-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:19564549-Kidney, pubmed-meshheading:19564549-Mice, pubmed-meshheading:19564549-Mice, Knockout, pubmed-meshheading:19564549-Muscle, Smooth, Vascular, pubmed-meshheading:19564549-Probability, pubmed-meshheading:19564549-Random Allocation, pubmed-meshheading:19564549-Rats, pubmed-meshheading:19564549-Rats, Sprague-Dawley, pubmed-meshheading:19564549-Species Specificity
pubmed:year
2009
pubmed:articleTitle
Growth arrest specific protein 6 participates in DOCA-induced target-organ damage.
pubmed:affiliation
Robert-Rössle-Str 10, 13125 Berlin, Germany.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't